KLRK1 (KLRK1, killer cell lectin-like receptor subfamily K, member 1, HGNC:18788, D12S2489E, KLR, NKG2-D, NKG2D, NK cell receptor D, NKG2-D type II integral membrane protein) (Control Peptide)

General information
 

Name:
KLRK1 (KLRK1, killer cell lectin-like receptor subfamily K, member 1, HGNC:18788, D12S2489E, KLR, NKG2-D, NKG2D, NK cell receptor D, NKG2-D type II integral membrane protein) (Control Peptide)
Size:
0,1 mg
Catalog no:
MBS659333
Price:
492 EUR
 

Additional extra details
 

  • Other size

    please contact us to order other different size

    Tissue

    cell, control

    Description

    For cells, cell lines and tissues in culture till half confluency.Isotype or positive controls by peptides, antibodies and deactivated samples.Associated membrane protein types are lipopolysaccharide selective barriers. Biological membranes include cell membranes, outer coverings of cells or organelles that allow passage of certain proteins and nuclear membranes, which cover a cell nucleus; and tissue membranes, such as mucosae and serosae. ,Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.